@article{29addd1954334cb3bf66fec5f5a814ea,
title = "Interview with Prof. Naoto T. Ueno, an inflammatory breast cancer expert",
author = "Ueno, {Naoto T.} and Luo, {Aisling Y.} and Yixuan Zeng",
note = "Funding Information: The projects in his laboratory include elucidating the role and the underlying mechanism of several signaling pathways, including epidermal growth factor receptor (EGFR), transforming growth factor beta (TGF-β), c-Jun N-terminal kinase (JNK), and Axl receptor tyrosine kinase (AXL), in promoting the progression of TNBC and IBC. His research also focuses on determining the impact of the tumor microenvironment on the efficacy of targeted therapy and establishing novel therapeutic approaches by modulating the tumor microenvironment. His significant current extramural funding includes R01 and R21 grants from NIH, as well as grants from the Cancer Research and Prevention Institute of Texas, the US Department of Defense, and the Breast Cancer Research Foundation. He also has more than six ongoing investigator-initiated clinical trials for patients with IBC and TNBC.",
year = "2022",
month = oct,
doi = "10.21037/cco-22-78",
language = "English (US)",
volume = "11",
journal = "Chinese clinical oncology",
issn = "2304-3865",
publisher = "Society for Translational Medicine (STM)",
number = "5",
}